The association between Akt activation and resistance to hormone therapy in metastatic breast cancer
2006 · European Journal of Cancer · 117 citations
https://doi.org/10.1016/j.ejca.2005.11.025
A
Akemi Kataoka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
101
Papers
1.8K
Citations
24
h-index
35
i10-index
Akemi Kataoka is an academic researcher from Japanese Foundation For Cancer Research. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Risks and Factors & Reproductive Biology and Fertility. The author has an h-index of 24, co-authored 86 publications.
Papers by this author
worksWho are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
2021 · The Breast · 54 citations
https://doi.org/10.1016/j.breast.2021.07.021
Prognostic value of the combination of epidermal growth factor receptor and c-erbB-2 in breast cancer
2003 · Surgery · 52 citations
https://doi.org/10.1067/msy.2003.32
The clinical significance of MMP-1 expression in oesophageal carcinoma
2001 · British Journal of Cancer · 49 citations
https://doi.org/10.1054/bjoc.2000.1568
Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study
2013 · Breast Cancer · 42 citations
https://doi.org/10.1007/s12282-013-0466-2
Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer
2003 · The American Journal of Surgery · 40 citations
https://doi.org/10.1016/s0002-9610(02)01203-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat